ResearcherUniversity of TsukubaActive in the last 2 years
Hiromitsu Nakahashi
Matched on ORCID iD 0009-0004-6419-0744; OpenAlex author ID A5040249013. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 2 papers
Papers 7
- Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2026.07.004↗
- Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics. First author DOI 10.1038/s41416-026-03577-w↗
- Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-02404-1↗
- Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. Co-author DOI 10.1186/s12957-025-03992-y↗
- Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. Co-author DOI 10.1155/2024/1529449↗
- Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer. First author DOI 10.3389/fcell.2024.1327772↗
- Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. Co-author DOI 10.1002/ijc.34362↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tatsuya Oda · 7 shared papers, 2023–2026 · strength 1.47
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-025-02404-1↗
- Paper Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics. DOI 10.1038/s41416-026-03577-w↗
- Osamu Shimomura · 7 shared papers, 2023–2026 · strength 1.47
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-025-02404-1↗
- Paper Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics. DOI 10.1038/s41416-026-03577-w↗
- Yoshihiro Miyazaki · 7 shared papers, 2023–2026 · strength 1.47
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-025-02404-1↗
- Paper Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics. DOI 10.1038/s41416-026-03577-w↗
- Yoshimasa Akashi · 5 shared papers, 2023–2026 · strength 1.03
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics. DOI 10.1038/s41416-026-03577-w↗
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Yukihito Kuroda · 4 shared papers, 2023–2026 · strength 0.78
- Paper Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics. DOI 10.1038/s41416-026-03577-w↗
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer. DOI 10.3389/fcell.2024.1327772↗
- Tomoaki Furuta · 3 shared papers, 2023–2026 · strength 0.61
- Paper Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2026.07.004↗
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Hiroaki Tateno · 3 shared papers, 2023–2025 · strength 0.61
- Paper Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-025-02404-1↗
- Paper Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. DOI 10.1155/2024/1529449↗
- Paper Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer. DOI 10.1002/ijc.34362↗
- Shuntaro Tsukamoto · 2 shared papers, 2025–2026 · strength 0.50
- Koichiro Kumano · 2 shared papers, 2024–2026 · strength 0.42
- Paper Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics. DOI 10.1038/s41416-026-03577-w↗
- Paper Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer. DOI 10.3389/fcell.2024.1327772↗
- Takahito Nakajima · 2 shared papers, 2023–2026 · strength 0.41
- Kentaro Hatano · 1 shared paper, 2026 · strength 0.25
- Tsuyoshi Enomoto · 1 shared paper, 2025 · strength 0.25
- Masato Endo · 1 shared paper, 2025 · strength 0.19
- Hideyuki Sakurai · 1 shared paper, 2025 · strength 0.19
- Kiichiro Tsuchiya · 1 shared paper, 2025 · strength 0.19
- Yuichi Hiroshima · 1 shared paper, 2025 · strength 0.19
- Haruko Numajiri · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.